日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial perturb-seq: single-cell functional genomics within intact tissue architecture

空间扰动测序:完整组织结构内的单细胞功能基因组学

Shen, Kimberle; Seow, Wan Yi; Keng, Choong Tat; Lim, Michelle Gek Liang; Lim, Daryl Shern; Guo, Ke; Meliani, Amine; Irfan Bin Hajis, Muhammad; Wang, Bolun; Prabhakar, Shyam; Chen, Kok Hao; Chew, Wei Leong

Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma

儿童横纹肌肉瘤的生物学进展和当前挑战

Hebron, Katie E; Odeniyide, Patience; Wei, Yun; Gryder, Berkley E; Barr, Frederic G; Casey, Dana L; Chen, Eleanor Y; Crompton, Brian D; Dela Cruz, Filemon S; Durbin, Adam D; Ford, Heide L; Gatz, Susanne A; Hatley, Mark E; Henssen, Anton G; Hettmer, Simone; Houghton, Peter J; Kendall, Genevieve C; Khan, Javed; Lupo, Philip J; Patel, Anand G; Pomella, Silvia; Rota, Rossella; Schito, Marco; Schoot, Reineke A; Shern, Jack F; Stanton, Benjamin Z; Stewart, Elizabeth A; Swindlehurst, Cathy A; Thomas, Craig J; Vakoc, Christopher R; Vaseva, Angelina V; Venkatramani, Rajkumar; Wexler, Leonard H; Yustein, Jason T; Hammond, Sharon; Heske, Christine M; Langenau, David M; Linardic, Corinne M; Ignatius, Myron S; Yohe, Marielle E

GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma

经NFAT诱导的膜锚定IL15/IL21改造的GPC2靶向CAR T细胞对神经母细胞瘤表现出增强的活性

Reona Okada ,Jeyshka M Reyes-González ,Constanza Rodriguez ,Taisuke Kondo ,Jangsuk Oh ,Ming Sun ,Michael C Kelly ,Ling Zhang ,James Gulley ,Jack F Shern ,Mitchell Ho ,Christian S Hinrichs ,Naomi N Taylor ,Xiyuan Zhang ,Rosa Nguyen

MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma.

MYCN 和 KAT2A 形成前馈回路,驱动神经母细胞瘤中的致癌转录程序

Liu Zhihui, Hong Jason J, Zhang Xiyuan, Sayers Carly M, Fang Wendy, Xu Man, Loria Sydney, Maskal Sakereh, Lei Haiyan, Wu Haitao, Swenson Rolf, Meier Jordan L, Shern Jack F, Thiele Carol J

Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancer.

直接 KRAS(G12C) 抑制剂在儿童癌症临床前模型中的活性。

Price Hannah E, Stauffer Stacey, Lee Hyun, Isanogle Kristine A, Wu Ying, Powell Katie, Baker Andrew, Stauffer Lucas, Perciaccante Andrew J, Jewell Connor P, Hernandez Edjay R, Aljabri Ashwaq K, Odeniyide Patience, Pratilas Christine A, Burgan William, Edmondson Elijah F, Difilippantonio Simone, Kortum Robert L, Shern Jack F, Jenkins Lisa M, Rossman Kent L, Yohe Marielle E

The Kinase Inhibitor GNF-7 Is Synthetically Lethal in Topoisomerase 1-Deficient Ewing Sarcoma.

激酶抑制剂 GNF-7 在拓扑异构酶 1 缺陷型尤文氏肉瘤中具有合成致死性

Sayers Carly M, Carter Morgan B, Lei Haiyan, Mendoza Arnulfo, Shema Steven, Zhang Xiaohu, Wilson Kelli, Chen Lu, Klumpp-Thomas Carleen, Thomas Craig J, Heske Christine M, Shern Jack F

The genetic landscape and classification of infantile epileptic spasms syndrome requiring surgery due to suspected focal brain malformations

因疑似局灶性脑畸形而需手术治疗的婴儿癫痫痉挛综合征的遗传概况和分类

Matthew Coleman, Min Wang, Penny Snell, Wei Shern Lee, Colleen D'Arcy, Cristina Mignone, Kate Pope, Greta Gillies, Wirginia Maixner, Alison Wray, A Simon Harvey, Cas Simons, Richard J Leventer, Sarah E M Stephenson, Paul J Lockhart, Katherine B Howell

ASAP1 and ARF1 Regulate Myogenic Differentiation in Rhabdomyosarcoma by Modulating TAZ Activity

ASAP1 和 ARF1 通过调节 TAZ 活性来调控横纹肌肉瘤的成肌分化

Katie E Hebron, Olivia L Perkins, Angela Kim, Xiaoying Jian, Sofia A Girald-Berlingeri, Haiyan Lei, Jack F Shern, Elizabeth A Conner, Paul A Randazzo, Marielle E Yohe

The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group

遗传祖先对儿童横纹肌肉瘤生存结局的影响:来自儿童肿瘤协作组的报告

Onwuka, Ekene A; Magyar, Christina L; Martin-Giacalone, Bailey A; Scheurer, Michael E; Marquez-Do, Deborah A; Zobeck, Mark; Atkinson, Elizabeth G; Rudzinski, Erin R; Arnold, Michael A; Barkauskas, Donald A; Hall, David; Khan, Javed; Shern, Jack F; Scheet, Paul; Crompton, Brian; Linardic, Corinne M; Hawkins, Douglas S; Venkatramani, Rajkumar; Mirabello, Lisa; Huff, Chad D; Richard, Melissa A; Lupo, Philip J

Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas

在免疫细胞数量升高时,白天服用SHP2抑制剂可缩小神经纤维瘤。

Niousha Ahmari ,Kwangmin Choi ,Jianqiang Wu ,Tilat A Rizvi ,Mark Jackson ,Leah J Kershner ,Mi-Ok Kim ,Xiyuan Zhang ,Eva Dombi ,Jack Shern ,David A Hildeman ,Nancy Ratner